Secondary Logo

Journal Logo

December 2011 - Volume 31 - Issue 6
pp: 685-821

Results From 2 Randomized, Double-Blind, Placebo-Controlled Studies of the Novel NK1 Receptor Antagonist Casopitant in Patients With Major Depressive Disorder

Ratti, Emiliangelo; Bellew, Kevin; Bettica, Paolo; More

Journal of Clinical Psychopharmacology. 31(6):727-733, December 2011.

PDF Only

A Double-Blind, Randomized, Controlled Trial of Fluoxetine Plus Quetiapine or Clomipramine Versus Fluoxetine Plus Placebo for Obsessive-Compulsive Disorder

Diniz, Juliana Belo; Shavitt, Roseli Gedanke; Fossaluza, Victor; More

Journal of Clinical Psychopharmacology. 31(6):763-768, December 2011.